INTRODUCTION {#SEC1}
============

Since the majority of genome-wide association study (GWAS) risk loci are located in the non-coding genomic region, identifying and interpreting how genetic variants in these loci regulate gene expression and then being able to explain disease susceptibility continues to be a challenge ([@B1]). An increasing number of studies have shown that associated variants for a particular trait/disease are significantly enriched in certain regulatory signals of the relevant tissues/cell types ([@B5],[@B6]). Therefore, integrating GWAS signals with coordinated genomic/epigenomic profiles in specific tissue/cell type provides a promising direction to fine-map the causal regulatory variant ([@B7]). In addition, connecting regulatory variants to their gene targets under a dynamic cellular environment is experimentally expensive, and computational methods are needed for more accurate predictions ([@B11]). However, recent international functional genomic projects, such as ENCODE and the 4D Nucleome project, continuously generate genome-wide chromosome conformation capture data, including Hi-C and ChIA-PET, on widespread tissues/cell types across human organs and development stages, which provides profound opportunities to study the effect of regulatory variants at spatiotemporal levels ([@B12]).

Previously, we developed the web server GWAS3D to detect human regulatory variants by the integrative analysis of genome-wide associations, chromosome interactions and histone modifications ([@B16]). This server has been successfully applied for functional fine-mapping and annotation of regulatory variants ([@B17],[@B18]). Compared with other widely used tools such as HaploReg ([@B19]) and RegulomeDB ([@B20]), our web server quantitatively prioritizes all associated SNPs in the linkage disequilibrium (LD) proxy and provides comprehensive functional annotations to interpret variant regulatory effects. During the past few years, several tools and resources have been developed to annotate regulatory variants ([@B21]). However, online tools that can incorporate tissue/cell-type-specific genomic/epigenomic information toward prioritizing disease-causal regulatory variants are still lacking. In this work, by integrating the latest multidimensional functional genomic resources and our recent regulatory variant prioritization method, cepip ([@B26]), we updated our previous web server to systematically analyze GWAS signals and to identify context-specific regulatory variants. The GWAS4D web server is freely available at <http://mulinlab.tmu.edu.cn/gwas4d> or <http://mulinlab.org/gwas4d>.

METHODS AND PIPELINE {#SEC2}
====================

GWAS4D has been improved substantially in its current form by incorporating uniformly processed genomic/epigenomic data, integrated transcription regulator motif data, and comprehensive functional annotations, as well as our recent prioritization method for regulatory variants. We illustrate the web server data and pipeline in the following sections.

Data collection and processing {#SEC2-1}
------------------------------

### Genetics data {#SEC2-1-1}

Genetic variant and allele information were retrieved from dbSNP150 ([@B27]) and 1000 Genomes Project phase 1 release ([@B28]). LD was computed by MACH using genotype information from 11 HapMap phases I + II + III subpopulations and four 1000 Genomes Project super populations (AFR, AMR, ASN and EUR) ([@B29],[@B30]). GENCODE v27 annotation was used to map genetic variants to gene loci ([@B31]).

### Tissue/cell-type-specific epigenome data {#SEC2-1-2}

Consolidated epigenomes from 127 human tissue/cell lines were downloaded from the web portal of the NIH Roadmap Epigenomics project ([@B32]), which includes narrow peaks from eight histone modifications ChIP-seq (H3K27ac, H3K27me3, H3K36me3, H3K4me1, H3K4me2, H3K4me3, H3K79me2 and H3K9me3) and DNase-seq. For tissue/cell lines with missing epigenomes, imputed narrow peaks were used.

### Tissue/cell-type-specific Hi-C data {#SEC2-1-3}

Genome-wide *in situ* or dilution Hi-C raw reads for diverse human tissue/cell lines were collected and downloaded from ENCODE, 4DN, GEO and published literature. To ensure relatively adequate read coverage for chromatin interaction identification at 5 Kb resolution, we required that each biological sample library should contain at least 150M sequenced reads. For the same tissue/cell line with multiple Hi-C libraries from different biological replicates or labs, we only kept the largest sequencing library. Using these criteria, GWAS4D now incorporates 60 Hi-C libraries from 14 human primary tissues and 46 human cell lines (see [Supplementary Table S1](#sup1){ref-type="supplementary-material"} for detailed information of the used Hi-C libraries). We uniformly processed these Hi-C data according to the HiC-Pro ([@B33]) standard analysis pipeline and considered significant chromatin interaction at 5 Kb resolution using HOMER ([@B34]) (see [Supplementary Table S1](#sup1){ref-type="supplementary-material"} for the number of significant interactions of each Hi-C library).

### Transcriptional regulator motif data {#SEC2-1-4}

Position frequency matrices of known and inferred transcription regulator motifs were curated and merged from 13 datasets ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Since a regulator may contain redundant or highly similar motifs, it is necessary to reduce the motif volume and select the representative ones. For each transcription regulator, we first used MACRO-APE ([@B35]) to calculate the pairwise similarity among collected motifs. We then clustered these motifs using the Calinski-Harabasz index ([@B36]) in the R fpc-package by dynamically setting the optimal number of clusters (no more than three clusters). We picked up the one representative motif with the largest information content in each cluster. Finally, GWAS4D compiles 3105 motifs for 1480 transcription regulators, providing an integrated compendium for evaluating variant effects on DNA--protein interactions.

### Regulatory variant annotation data {#SEC2-1-5}

Basic genomic features of genetic variants were retrieved through CADD base-wise annotations ([@B37]) and SNVrap ([@B38]). Variant allele frequency information was downloaded from gnomAD ([@B39]). GWAS4D also integrates multiple functional prediction scores of non-coding variants for all the possible single nucleotide variants from 10 algorithms ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Nonsynonymous mutation deleterious/pathogenic scores were received from the dbNSFP ([@B40]). Base-wise evolutionary scores were integrated from GADD and SiPhy ([@B41]). In addition, GWAS4D annotates variants using tissue/cell-type-specific regulatory signals, including open chromatin and histone modification data from the Roadmap Epigenomics project, transcription factor binding data from the CistromeDB ([@B42]), and CAGE associated transcript signals from the FANTOM CAT ([@B43]). Finally, trait/disease-association data were downloaded from GWASdb ([@B44]), GWAS Catalog ([@B45]), ClinVar ([@B46]), COSMIC ([@B47]) and GTEx ([@B48]) (see [Supplementary Table S2](#sup1){ref-type="supplementary-material"} for detailed information of the annotations used).

### GWAS statistical fine-mapping data {#SEC2-1-6}

To validate the usability of the GWAS4D web server, we used a fine-mapped credible set of 161 coronary artery disease (CAD) risk loci from a recent GWAS meta-analysis ([@B49]). SNPs that overlapped with protein coding regions and splicing sites were filtered out according to VEP annotation ([@B50]). Using the remaining non-coding fine-mapped SNPs, we first evaluated whether the GWAS4D predictions differed when selecting CAD matched and unmatched cell types. We then divided the SNPs into four subsets using PAINTOR posterior probabilities in the whole credible set (confidence \>95%, confidence between 50% and 95%, confidence between 10% and 50% and confidence \<10%) ([@B51]). We investigated whether the GWAS4D prediction scores in the high confidence subset are larger than those in the low confidence subset. Finally, we inspected the ability of GWAS4D to disentangle true disease-causal regulatory variants from a risk locus containing SNPs with similar posterior probabilities of causality.

Context-specific prioritization of regulatory variants from GWAS signals {#SEC2-2}
------------------------------------------------------------------------

GWAS4D analyzes and prioritizes human regulatory variants after GWAS statistical mapping. GWAS4D utilizes multiple tissue/cell-type-specific functional evidence sources to fine-map potentially disease-causal regulatory variants. The overall workflow of GWAS4D is shown in Figure [1](#F1){ref-type="fig"}.

![The workflow of GWAS4D (see the description of prioritization pipeline for details).](gky407fig1){#F1}

### SNP filtering and LD expansion {#SEC2-2-1}

GWAS4D accepts multiple variant description formats including VCF-like, dbSNP ID and coordinate-only. Variants not using the VCF-like format will be automatically lifted to dbSNP150 and assigned respective reference/1^st^ alternative alleles using SNPTracker ([@B52]). The web server will discard the variants not mapped onto dbSNP150 or 1000 Genomes Project unless the VCF-like format is used. The GWAS *P*-value is optimal but could be used to filter out less significant signals. For each leading SNP, GWAS4D can retrieve all linked SNPs in the corresponding LD proxy by a user-defined population and r-squared (*r*^2^) cutoff. However, this LD expansion can be disabled when input variants are a statistically fine-mapped GWAS credible set.

### Prediction of tissue/cell-type-specific regulatory probability {#SEC2-2-2}

To predict the regulatory probability of a genetic variant in a particular tissue/cell type, we used our recently developed context-dependent epigenomic weighting method, cepip ([@B26]). Given a defined tissue/cell type, GWAS4D utilizes cepip to score each SNP after filtering and LD expansion steps. In general, GWAS4D will report three probabilities: (i) 'composite P' shows the likelihood of the variant to be functional in gene regulation by our context-free ensemble method ([@B53]); (ii) 'cell P' represents the condition-dependent regulatory potential in the current tissue/cell type; (iii) 'combined P' is the final regulatory probability that jointly considers both context-free and context-dependent models. For a GWAS trait with unknown causal tissue/cell type, GWAS4D estimates the most relevant tissue/cell type by comparing the normalized mean 'cell P' of input GWAS signals across 127 reference tissue/cell types ([@B26]).

### Prediction of the regulatory effect on TF binding {#SEC2-2-3}

GWAS4D substantially extends the search pool of transcription regulator motifs and is able to scan as many as 3105 motifs for 1480 regulators. Using the same motif scanning and scoring strategy as in the GWAS3D, GWAS4D evaluates the difference of the transcription regulator binding affinity caused by different alleles from the investigated variant. The statistical significance of the variant effect was measured by a permutated null distribution of binding affinity differences.

### Prioritization and annotation of scored SNPs {#SEC2-2-4}

Given the number (*N*) of independent regulatory signals in each *r*^2^-defined LD proxy of GWAS leading variant, GWAS4D prioritizes all the scored variants and recommends the top N variants according to the 'combined P' in the corresponding LD proxy. GWAS4D also investigates whether the 'cell P' of the regulatory variant is top ranked across all 127 epigenome datasets to define the likely tissue/cell-type specificity. In addition, GWAS4D reports the top possible transcription regulators altered by the variant effect as well as their relevant motifs. To comprehensively exploit the variant regulatory effect, GWAS4D provides a batch of annotations and functional evidence, including variant genomic features, variant allele frequency, non-coding variant functional prediction scores, conservation scores, chromatin states, transcription factor binding events, expression quantitative trait loci (eQTLs) as well as many trait/disease associations. These annotations were indexed and randomly accessed by Tabix ([@B54]).

### Linking a regulatory variant to its target loci {#SEC2-2-5}

After the SNP prioritization step, GWAS4D maps the variant locus to genes using GENCODE annotations and records the chromosome ideogram if the variant locates in the intergenic region. GWAS4D also utilizes significant 5 kb Hi-C interactions of selected tissue/cell types to link the regulatory variant to its target loci. Considering SNP-located 5 kb bin as a virtual 4C viewpoint, the top 20 significant chromatin interactions in the same chromosome were plotted using CHiCP ([@B55]). Additionally, GWAS will display the peak signals of active or repressive chromatin marks within the viewpoint and target bins using Roadmap Epigenomics annotation tracks of the selected tissue/cell type.

WEB SERVER DESCRIPTION {#SEC3}
======================

Usage and interface {#SEC3-1}
-------------------

The GWAS4D web server accepts any of the four following GWAS variants input formats: VCF-like, coordinate-only, dbSNP ID and PLINK-like. Since the last three formats do not contain allele information, GWAS4D will supply respective alleles using reference/first alternative alleles in dbSNP 150 and 1000 Genomes Project and will discard variants that cannot map to these two datasets. Therefore, the VCF-like format is the suggested input format. Both plain text and uploaded file of GWAS variants are well supported, and the *P*-value is an optional input field and is used to filter less significant variants. To search correlated SNPs in the LD proxy of a leading variant, users can define a reference LD dataset and corresponding *r*^2^ cutoff on either the 1000 Genomes or HapMap populations. In the case where input variants are statistically fine-mapped GWAS signals, users could skip the LD expansion function by checking 'No LD Expansion'. By default, GWAS4D assumes that there is only one independent regulatory SNP in each LD proxy of leading variant and outputs the top scored SNP according to its 'combined P' value, but users can adjust the number of top prioritized variants in each LD proxy. To perform context-specific prioritization, users can select the epigenomes of a tissue/cell type from 127 reference tissue/cell types or upload narrow peaks of chromatin marks for a particular tissue/cell type. GWAS4D will automatically match an empirically relevant Hi-C dataset upon the selection of the reference tissue/cell type, but users are suggested to manually confirm or upload matched tissue/cell type-specific Hi-C interactions for better interpretation of target regions of regulatory SNP. In addition, GWAS4D allows one to estimate the likely relevant tissue/cell type if the user cannot assign a GWAS trait-associated tissue/cell type. Finally, users are able to customize the list of transcription regulators for motif scanning and to define the significance cutoff of the variant effect on the transcription regulator binding. GWAS4D allows three types of job retrieving methods, including encrypted link, job menu and email notification.

The GWAS4D platform displays the results in a highly interactive and user-friendly interface. Once the submitted job is finished, the URL is redirected to the result page (Figure [2](#F2){ref-type="fig"}). The left panel of the result page shows a table with the final results of prioritization, in which the regulatory SNPs are ordered according to the 'combined P' scores (Figure [2A](#F2){ref-type="fig"}). This searchable table also summarizes the genomics position of the variant, allele information and the relationship with the leading GWAS SNP. Importantly, to highlight the regulatory effect of each prioritized SNP, color marks were used in the last column of the prioritization table. For example, the SNP with the most significant transcription regulatory binding affinity change will be marked by an orange stamp, and the SNP fetching tissue/cell-type-specific 'cell P' under the current condition will be marked by a blue stamp, and the SNP located in the significant chromatin interaction region will be marked by a green stamp. By hovering over each regulatory SNP, users can inspect more information about the predicted regulatory scores. In addition to the detailed description of the SNP regulatory effect, GWAS4D also introduces an interactive circular plot using CHiCP to display the top most significant 5 kb chromatin interactions by assigning virtual 4C viewpoint to the SNP-contained locus. Chromatin marks within the connected 5 kb bins can also be showed when users click on each interaction arc (Figure [2B](#F2){ref-type="fig"}). The whole prioritization table can be downloaded with a tabular file. The right panel of the results page provides functional evidence and annotations of the regulatory variant in several categories (Figure [2C](#F2){ref-type="fig"}). The 'Variant Information' tab reports the variant\'s genomic attributes and allele frequency in the world-wide human population; the 'Functional Evidence' tab shows information of the SNP-altered transcription regulator binding affinity change, as well as several regulatory signals in the variant locus, such as transcriptional factor ChIP-seq peaks from CistromeDB and CAGE cluster signal from FANTOM CAT; the 'Functional Prediction' tab lists base-wise non-coding/coding functional prediction scores and conservation scores from multiple algorithms; the 'Trait/disease Association' tab presents trait/disease-associated records from GTEx, GWASdb, ClinVar and COSMIC; the 'External Link' tab links the SNP to several commonly used non-coding variant annotation resources including HaploReg ([@B19]), RegulomeDB ([@B20]), rSNPBase ([@B21]) and 3DSNP ([@B23]). Users can download all of the functional predictions and annotation information for each prioritized variant by simply clicking the download icon in the variant prioritization table.

![The result pages of the GWAS4D web server. (**A**) final prioritization table of GWAS4D; (**B**) virtual 4C circular plot for the top most significant Hi-C interactions between the variant locus and the target regions; (**C**) functional annotation tabs for prioritized SNPs.](gky407fig2){#F2}

Web server design {#SEC3-2}
-----------------

The GWAS4D web server was built on a Perl-based web framework, 'Catalyst'. The annotation information was indexed and retrieved by MySQL and Tabix. The Oracle Grid Engine was used as the job management system for task submission, and JQuery and related JavaScript UI components were used to construct the interactive web pages. GWAS4D now supports no \>10 000 significant input variants under the 'without LD extension' mode and 2500 significant input variants under the 'LD extension' mode. Usually, GWAS4D can finish conventional GWAS jobs in approximately 10 minutes ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}).

Evaluation {#SEC3-3}
----------

The overall performance of the applied method for regulatory variant prioritization has been benchmarked in our previous publications ([@B26],[@B53]). Here, we used a GWAS fine-mapped credible set at 161 CAD risk loci as an example to demonstrate one of the applications and the effectiveness of our GWAS4D web server. We first executed the GWAS4D with the 'no LD expansion' mode on 1699 non-coding CAD-associated SNPs using HUVEC, HepG2 and GM12878 epigenomes. We observed that the HUVEC-based 'combined P' scores were significantly higher than HepG2, GM12878-based 'combined P' scores for these credible SNPs (*P*-value = 5.2E--5 and 1.2E--10, respectively, Mann--Whitney U test), indicating that selecting relevant tissue/cell types that match GWAS traits/diseases may improve the detection of causal regulatory variants ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). By partitioning the fine-mapped SNPs into four separate subsets, we also showed that SNPs in the \>95% confidence subset obtained larger 'combined P' scores than those in the low confidence subsets (*P*-value = 0.039 by comparing \>95% confidence subset with \<10% confidence subset, Mann--Whitney U test) ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). This result suggests that GWAS4D could accurately prioritize disease-causal regulatory variants. In addition, we further exploited whether GWAS4D can distinguish true causal SNPs from a difficult credible set in which highly linked SNPs achieve a similar posterior probability of causality. We selected a credible set containing five SNPs with a posterior probability approximately 0.2 at the SMAD3 locus on chromosome 15. GWAS4D evaluated these five SNPs using the HUVEC cell type and prioritized them according to their 'combined P' scores ([Supplementary Table S4](#sup1){ref-type="supplementary-material"}). The top ranked SNP, rs17293632, did not obtain the highest posterior probability in the previous fine-mapping, but it overlaps with many active regulatory signals (DNA hypersensitive site, H3K27ac, H3K4me1, H3K4me2 and H3K4me3), eQTL and conservative regions. The HUVEC Hi-C data shows that the SNP locus interacts with the SMAD3 alternative promoter region at 5 kb resolution ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). GWAS4D also identifies that this variant could possibly disrupt the binding of AP-1 transcription factor JunB ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}). Taken together, these results are largely consistent with two recent studies regarding functional validations of rs17293632 at the SMAD3 locus that confers CAD risk ([@B56],[@B57]).

Few web servers that can incorporate tissue/cell-type-specific genomic/epigenomic information toward prioritizing and annotating disease-causal regulatory variants. Compared with the available features among several new or commonly used online resources, including HaploReg ([@B19]), RegulomeDB ([@B20]), rSNPBase ([@B21]), 3DSNP ([@B23]) and PINES (<https://doi.org/10.1101/083642>) and FUMA ([@B25]), we found that our GWAS4D provides the most comprehensive information and functions in the identification of tissue/cell type-specific regulatory variants ([Supplementary Table S5](#sup1){ref-type="supplementary-material"}).

CONCLUSION {#SEC4}
==========

Recent large-scale functional genomic/epigenomic studies have significantly expanded DNA regulatory codes in diverse human tissue/cell types. Connecting such effects with trait/disease associations to fine-map causal regulatory variants and their target genes is important in the post-GWAS era. By equipping our latest regulatory variant prioritization algorithm, comprehensive and up-to-date functional genomics resources, as well as an interactive user interface, GWAS4D systematically investigates the regulatory effect of GWAS SNPs in a tissue/cell-type-specific manner. Using relevant genomic/epigenomic data that matches GWAS traits/diseases, GWAS4D is able to enumerate and prioritize the likely functional SNPs in the LD proxy of each GWAS signal or re-evaluate the causal probability of regulatory variants based only on statistically fine-mapped GWAS SNPs. Additionally, GWAS4D incorporates our uniformly processed Hi-C chromatin interaction data at 5 kb resolution for 60 human primary tissue/cell lines, which provides a unique compendium to connect the genetic loci of diseases with their regulated targets. We expect GWAS4D to greatly aid researchers in investigating the genetic mechanisms of disease and to create more significant impacts in the era of human non-coding genomics.
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